ATHENEX INC (ATNX)
US04685N2027 - Common Stock
Athenex, Inc. 與貸方達成協議，推動快速銷售進程
為更好地推進事務發展，公司自願申請第 11 章破產程序 公司擁有足夠的資源支援 Athenex Pharma Solutions 的營運，並在此進程期間，完成 APD 客戶訂單 紐約布法羅, May 15, 2023 (GLOBE NEWSWIRE) -- Athenex, Inc.,...
SOFI Stock Sinks 10% on Analyst Downgrade
SoFi Technologies (SOFI) stock is on the move Monday after the finance company's stock was hit with a downgrade Wedbush.
Why Is Greenbrook TMS (GBNH) Stock Down 9% Today?
Greenbrook TMS (GBNH) stock is on the move Monday as the therapy center prepares to release its latest earnings report later today.
Why Is Athenex (ATNX) Stock Down 54% Today?
Athenex (ATNX) stock is falling on Monday after the company announced an agreement with lenders to pursue an expedited sales process.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
We're starting off the week with a breakdown of the biggest pre-market stock movers worth keeping an eye on Monday morning!
US Credit Crunch Claims Seven More Firms Filing for Bankruptcy
Media upstart Vice Media LLC and home security company Monitronics International Inc. were among at least seven firms filing for US Chapter 11 bankruptcy protection in the past 24 hours as companies feel the crunch from a year of interest hikes.
Athenex stock falls after bankruptcy filing (NASDAQ:ATNX)
Athenex (ATNX) lost ~52% pre-market Monday after announcing that the biotech and some of its subsidiaries filed for Chapter 11 bankruptcy in Texas. Read more here.
Athenex, Inc. Reaches Agreement With Lenders to Pursue Expedited Sales Process
Athenex, Inc. Reaches Agreement With Lenders to Pursue Expedited Sales Process
To Best Facilitate, Company Voluntarily Files Chapter 11 Proceedings Company Has Sufficient Resources to Support Athenex Pharma Solutions Operations and...
Quantum Leap Healthcare Collaborative Announces Result of Oral Paclitaxel in Combination with a PD-1 and Carboplatin from I-SPY2 TRIAL at ASCO
/PRNewswire/ -- Quantum Leap Healthcare Collaborative (Quantum Leap) and Athenex, Inc. (Nasdaq: ATNX) will present the findings of the I-SPY 2 TRIAL evaluation...
Athenex 發布 2022 年第四季度及全年財務業績及業務更新
探索一系列戰略備選方案 2022 年第四季度來自持續經營的產品銷售收入同比增長 +27%，2022 年全年增長 +33% Athenex 於 2022年第四季度應佔淨虧損為 3,420 萬美元，或每股經攤薄股份 4.28 美元，而上年同期為 1.044 億美元，或每股經攤薄股份 19.08 美元 ...
Athenex Provides Fourth Quarter and Full Year 2022 Financial Results and Business Update
Athenex Provides Fourth Quarter and Full Year 2022 Financial Results and Business Update
Exploring a range of strategic alternatives Revenues from product sales from continued operations increased +27% Y/Y in 4Q 2022 and +33% for full year...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time to start the day with an overview of the biggest pre-market stock movers worth keeping an eye on Thursday morning!
Athenex 宣佈反向股票分割
紐約州布法羅市, Feb. 15, 2023 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ：ATNX)，一家致力於癌症和相關疾病治療新療法的發現、開發和商業化的全球生物製藥公司今天宣佈，將於 2023 年 2 月 15 日東部時間上午 12:01...
Athenex launches 1-for-20 reverse stock split (NASDAQ:ATNX)
Athenex (ATNX) on Tuesday said it will effect a 1-for-20 reverse stock split of its issued common stock.
Athenex Announces a Reverse Stock Split
Athenex Announces a Reverse Stock Split
BUFFALO, N.Y., Feb. 14, 2023 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery,...
Athenex 宣佈 MHRA 關於口服紫杉醇的決定
MHRA 僅以化學成分、生產和控制 (CMC) 問題為由拒絕了口服紫杉醇治療轉移性乳腺癌的申請Athenex 計劃要求一個獨立小組對 MHRA 的決定進行審查 MHRA 的申請補充了來自 iSPY 2 研究的安全性數據，未表現出重大臨床療效或安全性問題 紐約州布法羅, Jan. 04, 2023 ...